Recent Finacing
Recent Raise
Respirion develops an inhaled tobramycin therapy with a metal‑chelating adjuvant in a novel formulation and delivery device to disrupt biofilms, conducting clinical trials under US and Australian regulations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor